The future of nanovaccines looks promising, with ongoing research and development aimed at overcoming current challenges. Advances in nanomedicine and materials science are expected to lead to more effective and safer nanovaccines. Additionally, the COVID-19 pandemic has accelerated interest and investment in this field, paving the way for rapid advancements and potential breakthroughs.
